Publications by authors named "Kohn D"

Background: Changes of patellar position (height, tilt, and shift) and arthritis of the patellofemoral joint might potentially influence outcome after unicompartmental knee replacement.

Objectives: The purpose of this work is to evaluate the influence of the aforementioned parameters on postoperative outcome.

Methods: Literature analysis via PubMed.

View Article and Find Full Text PDF

Cell instructive mineralized biomaterials are a promising alternative to conventional auto-, allo-, and xenograft therapies for the reconstruction of critical sized defects. Extracellular matrix proteins, peptide domains, and functional motifs demonstrating cell and mineral binding activity have been used to improve cell attachment. However, these strategies vary in their tissue regeneration outcomes due to lack of specificity to both regenerative cell populations and the material substrates.

View Article and Find Full Text PDF

In this issue of , Girard-Gagnepain et al report a potentially important discovery for improved gene transfer to human hematopoietic stem cells (HSCs) for gene therapy of blood cell diseases: a novel retroviral envelope to package (pseudotype) vectors for enhanced gene delivery to human HSCs.

View Article and Find Full Text PDF

Importance: Newborn screening for severe combined immunodeficiency (SCID) using assays to detect T-cell receptor excision circles (TRECs) began in Wisconsin in 2008, and SCID was added to the national recommended uniform panel for newborn screened disorders in 2010. Currently 23 states, the District of Columbia, and the Navajo Nation conduct population-wide newborn screening for SCID. The incidence of SCID is estimated at 1 in 100,000 births.

View Article and Find Full Text PDF

Background: The Primary Immune Deficiency Treatment Consortium was formed to analyze the results of hematopoietic-cell transplantation in children with severe combined immunodeficiency (SCID) and other primary immunodeficiencies. Factors associated with a good transplantation outcome need to be identified in order to design safer and more effective curative therapy, particularly for children with SCID diagnosed at birth.

Methods: We collected data retrospectively from 240 infants with SCID who had received transplants at 25 centers during a 10-year period (2000 through 2009).

View Article and Find Full Text PDF

Renewable energy resources can indisputably minimize the threat of global warming and climate change. However, they are intermittent and need buffer storage to bridge the time-gap between production (off peak) and demand peaks. Based on geologic and geochemical reasons, the North German Basin has a very large capacity for compressed air/gas energy storage CAES in porous saltwater aquifers and salt cavities.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers have developed a new treatment for monogenic diseases using lentiviral vectors carrying therapeutic genes, specifically aimed at addressing adenosine deaminase (ADA) deficiency.
  • Experiments showed that HIV-1-based vectors, particularly those using vesicular stomatitis virus glycoprotein, were more effective in delivering the gene and achieving higher copy numbers in tissues of ADA-deficient mice and newborn rhesus monkeys.
  • The findings indicate that this gene delivery method has potential for clinical applications, especially for ADA-deficient patients who have limited options for stem cell transplants.
View Article and Find Full Text PDF

Reducing the data collection time without affecting the signal intensity and spectral resolution is one of the major challenges for the widespread application of multidimensional nuclear magnetic resonance (NMR) spectroscopy, especially in experiments conducted on complex heterogeneous biological systems such as bone. In most of these experiments, the NMR data collection time is ultimately governed by the proton spin-lattice relaxation times (T1). For over two decades, gadolinium(III)-DTPA (Gd-DTPA, DTPA=Diethylene triamine pentaacetic acid) has been one of the most widely used contrast-enhancement agents in magnetic resonance imaging (MRI).

View Article and Find Full Text PDF

Recently, the gene therapy field has begun to experience clinical successes in a number of different diseases using various approaches and vectors. The workshop Gene Therapy: Charting a Future Course, sponsored by the National Institutes of Health (NIH) Office of Biotechnology Activities, brought together early and mid-career researchers to discuss the key scientific challenges and opportunities, ethical and communication issues, and NIH and foundation resources available to facilitate further clinical advances.

View Article and Find Full Text PDF

Despite the power of model systems to reveal basic immunologic mechanisms, critical differences exist between species that necessitate the direct study of human cells. Illustrating this point is the difference in phenotype between patients with SCID caused by mutations affecting the common γ-chain (γc) cytokine signaling pathway and mice with similar mutations. Although in both species, null mutations in either IL-2RG (which encodes γc), or its direct downstream signaling partner JAK3, result in T and NK cell deficiency, an associated B cell deficiency is seen in mice but not in humans with these genetic defects.

View Article and Find Full Text PDF

Unlimited self renewal capacity and differentiation potential make human pluripotent stem cells (PSC) a promising source for the ex vivo manufacture of red blood cells (RBCs) for safe transfusion. Current methods to induce erythropoiesis from PSC suffer from low yields of RBCs, most of which are immature and contain embryonic and fetal rather than adult hemoglobins. We have previously shown that homodimerization of the intracellular component of MPL (ic-MPL) induces erythropoiesis from human cord blood progenitors.

View Article and Find Full Text PDF

Purpose: It has been demonstrated that large numbers of tumor-specific T cells for adoptive cell transfer (ACT) can be manufactured by retroviral genetic engineering of autologous peripheral blood lymphocytes and expanding them over several weeks. In mouse models, this therapy is optimized when administered with dendritic cell (DC) vaccination. We developed a short 1-week manufacture protocol to determine the feasibility, safety, and antitumor efficacy of this double cell therapy.

View Article and Find Full Text PDF

Multiple sclerosis is an inflammatory disease of the central nervous system. Chronic pain is one of the main symptoms, affecting many patients. Studies show that the lignans or the apolar extracts of Phyllanthus amarus have antinociceptive effects in different animal models.

View Article and Find Full Text PDF
Article Synopsis
  • Integrase-defective lentiviral vectors (IDLVs) struggle to effectively deliver zinc finger nucleases (ZFNs) to human cells due to low gene expression, often influenced by epigenetic silencing.
  • In this study, the HDAC inhibitor valproic acid (VPA) was tested and found to enhance ZFN expression from IDLVs by up to three times in K562 cells, leading to better disruption of the ADA gene.
  • Other FDA-approved HDAC inhibitors also showed similar benefits in increasing ZFN activity in both K562 and primary human CD34(+) cells, with cell cycle modulation identified as a major driver for improved gene expression.
View Article and Find Full Text PDF

Hematopoietic stem cells (HSCs) provide an attractive target for immunotherapy of cancer and leukemia by the introduction of genes encoding T-cell receptors (TCRs) or chimeric antigen receptors (CARs) directed against tumor-associated antigens. HSCs engraft for long-term blood cell production and could provide a continuous source of targeted anti-cancer effector cells to sustain remissions. T cells produced de novo from HSCs may continuously replenish anti-tumor T cells that have become anergic or exhausted from ex vivo expansion or exposure to the intratumoral microenvironment.

View Article and Find Full Text PDF

Background: The approach to the diagnosis of severe combined immunodeficiency disease (SCID) and related disorders varies among institutions and countries.

Objectives: The Primary Immune Deficiency Treatment Consortium attempted to develop a uniform set of criteria for diagnosing SCID and related disorders and has evaluated the results as part of a retrospective study of SCID in North America.

Methods: Clinical records from 2000 through 2009 at 27 centers in North America were collected on 332 children treated with hematopoietic stem cell transplantation (HCT), enzyme replacement therapy, or gene therapy for SCID and related disorders.

View Article and Find Full Text PDF

The relationship between the cells that initiate cancer and the cancer stem-like cells that propagate tumors has been poorly defined. In a human prostate tissue transformation model, basal cells expressing the oncogenes Myc and myristoylated AKT can initiate heterogeneous tumors. Tumors contain features of acinar-type adenocarcinoma with elevated eIF4E-driven protein translation and squamous cell carcinoma marked by activated beta-catenin.

View Article and Find Full Text PDF

Solid-state (magic-angle spinning) NMR spectroscopy is a useful tool for obtaining structural information on bone organic and mineral components and synthetic model minerals at the atomic-level. Raman and P NMR spectral parameters were investigated in a series of synthetic B-type carbonated apatites (CAps). Inverse P NMR linewidth and inverse Raman PO ν bandwidth were both correlated with powder XRD crystallinity over the 0.

View Article and Find Full Text PDF
Article Synopsis
  • Gene transfer using self-inactivating lentiviral vectors (LV), specifically LV EFS ADA, shows promise as a safer and more effective gene therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID) compared to traditional γ-retroviral vectors (gRV).
  • In studies with ADA(-/-) mice, LV EFS ADA provided successful gene transfer and restored sufficient ADA enzyme levels, leading to recovery from lethal conditions and improved immune function.
  • The LV EFS ADA vector demonstrated a significantly lower risk of insertional mutagenesis—an issue seen in gRV vectors—indicating it may pose fewer risks for patients undergoing gene therapy.
View Article and Find Full Text PDF

The Primary Immune Deficiency Treatment Consortium (PIDTC) is a network of 33 centers in North America that study the treatment of rare and severe primary immunodeficiency diseases. Current protocols address the natural history of patients treated for severe combined immunodeficiency (SCID), Wiskott-Aldrich syndrome, and chronic granulomatous disease through retrospective, prospective, and cross-sectional studies. The PIDTC additionally seeks to encourage training of junior investigators, establish partnerships with European and other International colleagues, work with patient advocacy groups to promote community awareness, and conduct pilot demonstration projects.

View Article and Find Full Text PDF